Manmeet Singh Ahluwalia, MD, MBA, FASCO, discusses oncology advances that were highlighted at the Miami Cancer Institute Precision Oncology Symposium.
Manmeet S. Ahluwalia, MD, MBA, FASCO
Advertisement
Manmeet S. Ahluwalia, MD, MBA, FASCO, is the deputy pirector, chief scientific officer, chief of medical oncology, and Fernandez Family Foundation Endowed Chair in Cancer Research at Miami Cancer Institute, which is part of Baptist Health South Florida.
Articles by Manmeet S. Ahluwalia, MD, MBA, FASCO
Although novel therapies have improved cancer care, cancer diagnoses have increased, with more than 2 million new cases estimated for 2024.
Advertisement
Latest Updated Articles
2024 Outlook on Cancer Care: Striving to Overcome the ChallengesPublished: March 5th 2024 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5